Abstract
Objective
To explore the association between the creatinine clearance rate (Ccr) and the prognosis of patients, and compared with estimated glomerular filtration rate (eGFR).
Methods
We retrospectively collected information of patients with SLE who were first hospitalized between 1999 and 2009 in Jiangsu Province, China, and followed up in 2010 and 2015. Ccr was calculated and dichotomized into normal group (Ccr ≥ 70) and decreasing group (Ccr < 70). The clinical characteristics of the two groups were compared and Cox proportional-hazards regression models were used to calculate hazard ratio (HR) and 95% confidence interval (CI).
Results
Among 1990 SLE patients, we observed 437 (22.0%) with decreased Ccr, including 237 cases (11.9%) with mild renal dysfunction, 136 cases (6.8%) with moderate renal dysfunction, and 64 cases (3.2%) with severe renal dysfunction. Compared to normal Ccr, decreasing Ccr had a higher risk for mortality with adjusted HR (95% CI) of 2.21 (1.59–3.06). Dose-response relationships were significantly found between increased mortality of SLE and decreased Ccr (p for trend < 0. 001), as well as eGFR. Positive associations were consistently observed in subgroups, such as systemic lupus disease activity index (SLEDAI) ≥ 15, without comorbidities and abnormal laboratory indexes. Decreasing Ccr was positively associated with mortality from infection and renal failure with HR (95% CI) of 1.80 (1.02–3.19) and 6.84 (3.05–15.36).
Conclusions
A significant association has been observed between decreased Ccr and increased risk for mortality of SLE patients. Early clinical interventions to modulate the Ccr of SLE patients may be beneficial to their survival.
Key points • Decreasing creatinine clearance rate (Ccr) was positively associated with an overall mortality of SLE patients, with a dose-response relationship. • Moreover, decreasing Ccr was associated with elevated mortality primarily due to infection and renal failure. |
Similar content being viewed by others
Availability of data and material
The raw data required to reproduce these findings cannot be shared at this time as the data also forms part of other ongoing studies.
References
Park SY, Joo YB, Shim J, Sung YK, Bae SC (2015) Direct medical costs and their predictors in South Korean patients with systemic lupus erythematosus. Rheumatol Int 35(11):1809–1815. https://doi.org/10.1007/s00296-015-3344-8
Serrano-Aguilar P, Trujillo-Martin Mdel M, Perez de la Rosa A, Cuellar-Pompa L, Saavedra-Medina H, Linertova R, Perestelo-Perez L, Perez-Ramos J, Rivero-Santana A, Spanish SLECPGDG (2015) Patient participation in a clinical guideline development for systemic lupus erythematosus. Patient Educ Couns 98(9):1156–1163. https://doi.org/10.1016/j.pec.2015.05.022
Feng X, Pan W, Liu L, Wu M, Ding F, Hu H, Ding X, Wei H, Zou Y, Qian X, Wang M, Wu J, Tao J, Tan J, Da Z, Zhang M, Li J, Sun L, Jiangsu Lupus Collaborative G (2016) Prognosis for hospitalized patients with systemic lupus erythematosus in China: 5-year update of the Jiangsu cohort. PLoS One 11(12):e0168619. https://doi.org/10.1371/journal.pone.0168619
Wang Z, Li M, Wang Y, Xu D, Wang Q, Zhang S, Zhao J, Su J, Wu Q, Shi Q, Leng X, Zhang W, Tian X, Zhao Y, Zeng X (2018) Long-term mortality and morbidity of patients with systemic lupus erythematosus: a single-center cohort study in China. Lupus 27(5):864–869. https://doi.org/10.1177/0961203317751852
Mak A, Cheung MW, Chiew HJ, Liu Y, Ho RC (2012) Global trend of survival and damage of systemic lupus erythematosus: meta-analysis and meta-regression of observational studies from the 1950s to 2000s. Semin Arthritis Rheum 41(6):830–839. https://doi.org/10.1016/j.semarthrit.2011.11.002
Wada Y, Hasegawa H, Saeki T, Ito S, Kuroda T, Nakano M, Narita I (2018) Long-term prognosis and factors associated with damage accrual in Japanese patients with systemic lupus erythematosus. Clin Exp Nephrol 22(3):597–602. https://doi.org/10.1007/s10157-017-1491-9
Wang Z, Wang Y, Zhu R, Tian X, Xu D, Wang Q, Wu C, Zhang S, Zhao J, Zhao Y, Li M, Zeng X (2015) Long-term survival and death causes of systemic lupus erythematosus in China: a systemic review of observational studies. Medicine (Baltimore) 94(17):e794. https://doi.org/10.1097/MD.0000000000000794
Wu XY, Yang M, Xie YS, Xiao WG, Lin J, Zhou B, Guan X, Luo CN, Che N, Liu XZ, Wang C, Teng JL, Cheng XB, Ye JN, Su YT, Shi H, Yin YF, Liu MR, Sun Y, Hu QY, Zhou ZC, Chi HH, Liu Y, Zhang X, Chen JW, Zhang MJ, Zhao DB, Yang CD, Wu LJ, Liu HL (2019) Causes of death in hospitalized patients with systemic lupus erythematosus: a 10-year multicenter nationwide Chinese cohort. Clin Rheumatol 38(1):107–115. https://doi.org/10.1007/s10067-018-4259-z
Fei Y, Shi X, Gan F, Li X, Zhang W, Li M, Hou Y, Zhang X, Zhao Y, Zeng X, Zhang F (2014) Death causes and pathogens analysis of systemic lupus erythematosus during the past 26 years. Clin Rheumatol 33(1):57–63. https://doi.org/10.1007/s10067-013-2383-3
Gladman DD, Urowitz MB, Goldsmith CH, Fortin P, Ginzler E, Gordon C, Hanly JG, Isenberg DA, Kalunian K, Nived O, Petri M, Sanchez-Guerrero J, Snaith M, Sturfelt G (1997) The reliability of the Systemic Lupus International Collaborating Clinics/American College of Rheumatology Damage Index in patients with systemic lupus erythematosus. Arthritis Rheum 40(5):809–813. https://doi.org/10.1002/art.1780400506
Isenberg DA, Rahman A, Allen E, Farewell V, Akil M, Bruce IN, D’Cruz D, Griffiths B, Khamashta M, Maddison P, McHugh N, Snaith M, Teh LS, Yee CS, Zoma A, Gordon C (2005) BILAG 2004. Development and initial validation of an updated version of the British Isles Lupus Assessment Group’s disease activity index for patients with systemic lupus erythematosus. Rheumatology (Oxford) 44(7):902–906. https://doi.org/10.1093/rheumatology/keh624
Lin J, Knight EL, Hogan ML, Singh AK (2003) A comparison of prediction equations for estimating glomerular filtration rate in adults without kidney disease. J Am Soc Nephrol 14(10):2573–2580. https://doi.org/10.1097/01.asn.0000088721.98173.4b
Zuo L, Ma YC, Zhou YH, Wang M, Xu GB, Wang HY (2005) Application of GFR-estimating equations in Chinese patients with chronic kidney disease. Am J Kidney Dis 45(3):463–472. https://doi.org/10.1053/j.ajkd.2004.11.012
Levey AS, Stevens LA, Schmid CH, Zhang YL, Castro AF 3rd, Feldman HI, Kusek JW, Eggers P, Van Lente F, Greene T, Coresh J, Ckd EPI (2009) A new equation to estimate glomerular filtration rate. Ann Intern Med 150(9):604–612. https://doi.org/10.7326/0003-4819-150-9-200905050-00006
Shlipak MG, Matsushita K, Arnlov J, Inker LA, Katz R, Polkinghorne KR, Rothenbacher D, Sarnak MJ, Astor BC, Coresh J, Levey AS, Gansevoort RT, Consortium CKDP (2013) Cystatin C versus creatinine in determining risk based on kidney function. N Engl J Med 369(10):932–943. https://doi.org/10.1056/NEJMoa1214234
Cockcroft DW, Gault MH (1976) Prediction of creatinine clearance from serum creatinine. Nephron 16(1):31–41. https://doi.org/10.1159/000180580
National Kidney F (2002) K/DOQI clinical practice guidelines for chronic kidney disease: evaluation, classification, and stratification. Am J Kidney Dis 39(2 Suppl 1):S1–S266. https://doi.org/10.1111/j.1745-7599.2002.tb00119.x
Tan EM, Cohen AS, Fries JF, Masi AT, McShane DJ, Rothfield NF, Schaller JG, Talal N, Winchester RJ (1982) The 1982 revised criteria for the classification of systemic lupus erythematosus. Arthritis Rheum 25(11):1271–1277. https://doi.org/10.1002/art.1780251101
Hochberg MC (1997) Updating the American College of Rheumatology revised criteria for the classification of systemic lupus erythematosus. Arthritis Rheum 40(9):1725. https://doi.org/10.1002/art.1780400928
Bombardier C, Gladman DD, Urowitz MB, Caron D, Chang CH (1992) Derivation of the SLEDAI. A disease activity index for lupus patients. The Committee on Prognosis Studies in SLE. Arthritis Rheum 35(6):630–640. https://doi.org/10.1002/art.1780350606
Wu G, Jia X, Gao D, Zhao Z (2014) Survival rates and risk factors for mortality in systemic lupus erythematosus patients in a Chinese center. Clin Rheumatol 33(7):947–953. https://doi.org/10.1007/s10067-014-2596-0
Mageau A, Timsit JF, Perrozziello A, Ruckly S, Dupuis C, Bouadma L, Papo T, Sacre K (2019) The burden of chronic kidney disease in systemic lupus erythematosus: A nationwide epidemiologic study. Autoimmun Rev 18(7):733–737. https://doi.org/10.1016/j.autrev.2019.05.011
Hanly JG, O’Keeffe AG, Su L, Urowitz MB, Romero-Diaz J, Gordon C, Bae SC, Bernatsky S, Clarke AE, Wallace DJ, Merrill JT, Isenberg DA, Rahman A, Ginzler EM, Fortin P, Gladman DD, Sanchez-Guerrero J, Petri M, Bruce IN, Dooley MA, Ramsey-Goldman R, Aranow C, Alarcon GS, Fessler BJ, Steinsson K, Nived O, Sturfelt GK, Manzi S, Khamashta MA, van Vollenhoven RF, Zoma AA, Ramos-Casals M, Ruiz-Irastorza G, Lim SS, Stoll T, Inanc M, Kalunian KC, Kamen DL, Maddison P, Peschken CA, Jacobsen S, Askanase A, Theriault C, Thompson K, Farewell V (2016) The frequency and outcome of lupus nephritis: results from an international inception cohort study. Rheumatology (Oxford) 55(2):252–262. https://doi.org/10.1093/rheumatology/kev311
Thomas G, Mancini J, Jourde-Chiche N, Sarlon G, Amoura Z, Harle JR, Jougla E, Chiche L (2014) Mortality associated with systemic lupus erythematosus in France assessed by multiple-cause-of-death analysis. Arthritis Rheum 66(9):2503–2511. https://doi.org/10.1002/art.38731
Yee CS, Su L, Toescu V, Hickman R, Situnayake D, Bowman S, Farewell V, Gordon C (2015) Birmingham SLE cohort: outcomes of a large inception cohort followed for up to 21 years. Rheumatology (Oxford) 54(5):836–843. https://doi.org/10.1093/rheumatology/keu412
James MT, Laupland KB, Tonelli M, Manns BJ, Culleton BF, Hemmelgarn BR, Network AKD (2008) Risk of bloodstream infection in patients with chronic kidney disease not treated with dialysis. Arch Intern Med 168(21):2333–2339. https://doi.org/10.1001/archinte.168.21.2333
James MT, Quan H, Tonelli M, Manns BJ, Faris P, Laupland KB, Hemmelgarn BR, Alberta Kidney Disease N (2009) CKD and risk of hospitalization and death with pneumonia. Am J Kidney Dis 54(1):24–32. https://doi.org/10.1053/j.ajkd.2009.04.005
Dalrymple LS, Katz R, Kestenbaum B, de Boer IH, Fried L, Sarnak MJ, Shlipak MG (2012) The risk of infection-related hospitalization with decreased kidney function. Am J Kidney Dis 59(3):356–363. https://doi.org/10.1053/j.ajkd.2011.07.012
Nakayama M, Metoki H, Terawaki H, Ohkubo T, Kikuya M, Sato T, Nakayama K, Asayama K, Inoue R, Hashimoto J, Totsune K, Hoshi H, Ito S, Imai Y (2007) Kidney dysfunction as a risk factor for first symptomatic stroke events in a general japanese population--the Ohasama study. Nephrol Dial Transplant 22(7):1910–1915
Suzuki M, Ross GF, Wiers K, Nelson S, Bennett M, Passo MH, Devarajan P, Brunner HI (2007) Identification of a urinary proteomic signature for lupus nephritis in children. Pediatr Nephrol 22(12):2047–2057. https://doi.org/10.1007/s00467-007-0608-x
Mosley K, Tam FW, Edwards RJ, Crozier J, Pusey CD, Lightstone L (2006) Urinary proteomic profiles distinguish between active and inactive lupus nephritis. Rheumatology 45(12):1497–1504. https://doi.org/10.1093/rheumatology/kel351
Yu F, Tan Y, Liu G, Wang SX, Zou WZ, Zhao MH (2009) Clinicopathological characteristics and outcomes of patients with crescentic lupus nephritis. Kidney Int 76(3):307–317. https://doi.org/10.1038/ki.2009.136
López-Pelayo I, Mazuecos Blanca MA, García Palacios MV, Galán Sánchez F, López Rodríguez F, Bailén García MA (2019) How to manage kidney transplant recipients: deciding between glomerular filtration rate-estimating equations, creatinine clearance and albumin-creatinine ratio, or albumin excretion. Exp Clin Transplant 17(4):450–456. https://doi.org/10.6002/ect.2017.0335
Acknowledgments
The authors would like to thank all investigators and site staff of local hospitals who participated in this study and the Cinkate Corp for their assistance in helping built and manage our database website.
Funding
This work was supported by the Major International (Regional) Joint Research Project of China (No. 81720108020) and the Key Program of the National Natural Science Foundation of China (No. 81930043).
Author information
Authors and Affiliations
Contributions
Study conception and design: J.G., Z.J., L.S. Acquisition of data: X.F., W.P., L.L., Min W., H.H., X.D., H.W., Y.Z., X.Q., Meimei W., J.W., Juan T., Jun T., Z.D., M.Z., J.L., L.S. Analysis and drafting the article: J.G., Z.J. Revising the article: Z.J., L.S. All authors have finally approved the submitted version to be published.
Corresponding authors
Ethics declarations
Disclosures
None.
Code availability
No code was involved in this work.
Additional information
Publisher’s note
Springer Nature remains neutral with regard to jurisdictional claims in published maps and institutional affiliations.
Rights and permissions
About this article
Cite this article
Ge, J., Jin, Z., Feng, X. et al. Creatinine clearance rate predicts prognosis of patients with systemic lupus erythematosus: a large retrospective cohort study. Clin Rheumatol 40, 2221–2231 (2021). https://doi.org/10.1007/s10067-020-05485-7
Received:
Revised:
Accepted:
Published:
Issue Date:
DOI: https://doi.org/10.1007/s10067-020-05485-7